Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of Molecular and Cellular Cardiology
|
December 8, 2015
Gaining myocytes or losing fibroblasts: Challenges in cardiac fibroblast reprogramming for infarct repair
Raghu S Nagalingam, Hamza A Safi, Michael P Czubryt
Canadian Journal of Physiology and Pharmacology
|
November 24, 2018
What's in a name? On fibroblast phenotype and nomenclature <sup>1</sup>
Raghu S Nagalingam, Danah S Al-Hattab, Michael P Czubryt
The Journal of Biological Chemistry
|
August 9, 2014
Deficiency of cardiomyocyte-specific microRNA-378 contributes to the development of cardiac fibrosis involving a transforming growth factor β (TGFβ1)-dependent paracrine mechanism
Raghu S Nagalingam, Nagalingam R Sundaresan, Mariam Noor, et al.
The Journal of Biological Chemistry
|
March 1, 2013
A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling
Raghu S Nagalingam, Nagalingam R Sundaresan, Mahesh P Gupta, et al.
The Journal of Biological Chemistry
|
February 28, 2012
A novel cardiomyocyte-enriched microRNA, miR-378, targets insulin-like growth factor 1 receptor: implications in postnatal cardiac remodeling and cell survival
Ivana Knezevic, Aalok Patel, Nagalingam R Sundaresan, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
June 16, 2018
Scleraxis regulates Twist1 and Snai1 expression in the epithelial-to-mesenchymal transition
Danah S Al-Hattab, Hamza A Safi, Raghu S Nagalingam, et al.
American Journal of Physiology. Cell Physiology
|
July 1, 2016
Role of scleraxis in mechanical stretch-mediated regulation of cardiac myofibroblast phenotype
Patricia L Roche, Raghu S Nagalingam, Rushita A Bagchi, et al.
Canadian Journal of Physiology and Pharmacology
|
February 7, 2020
Scleraxis as a prognostic marker of myocardial fibrosis in hypertrophic cardiomyopathy (SPARC) study
Antonia Zhu, Hilary Bews, David Cheung, et al.
Journal of Molecular and Cellular Cardiology
|
May 12, 2018
Regulation of cardiac fibroblast MMP2 gene expression by scleraxis
Raghu S Nagalingam, Hamza A Safi, Danah S Al-Hattab, et al.
Cells
|
May 14, 2022
Regulation of Cardiac Fibroblast GLS1 Expression by Scleraxis
Sikta Chattopadhyaya, Raghu S Nagalingam, D Allison Ledingham, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of Molecular and Cellular Cardiology
|
December 8, 2015
Gaining myocytes or losing fibroblasts: Challenges in cardiac fibroblast reprogramming for infarct repair
Raghu S Nagalingam, Hamza A Safi, Michael P Czubryt
Canadian Journal of Physiology and Pharmacology
|
November 24, 2018
What's in a name? On fibroblast phenotype and nomenclature <sup>1</sup>
Raghu S Nagalingam, Danah S Al-Hattab, Michael P Czubryt
The Journal of Biological Chemistry
|
August 9, 2014
Deficiency of cardiomyocyte-specific microRNA-378 contributes to the development of cardiac fibrosis involving a transforming growth factor β (TGFβ1)-dependent paracrine mechanism
Raghu S Nagalingam, Nagalingam R Sundaresan, Mariam Noor, et al.
The Journal of Biological Chemistry
|
March 1, 2013
A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling
Raghu S Nagalingam, Nagalingam R Sundaresan, Mahesh P Gupta, et al.
The Journal of Biological Chemistry
|
February 28, 2012
A novel cardiomyocyte-enriched microRNA, miR-378, targets insulin-like growth factor 1 receptor: implications in postnatal cardiac remodeling and cell survival
Ivana Knezevic, Aalok Patel, Nagalingam R Sundaresan, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
June 16, 2018
Scleraxis regulates Twist1 and Snai1 expression in the epithelial-to-mesenchymal transition
Danah S Al-Hattab, Hamza A Safi, Raghu S Nagalingam, et al.
American Journal of Physiology. Cell Physiology
|
July 1, 2016
Role of scleraxis in mechanical stretch-mediated regulation of cardiac myofibroblast phenotype
Patricia L Roche, Raghu S Nagalingam, Rushita A Bagchi, et al.
Canadian Journal of Physiology and Pharmacology
|
February 7, 2020
Scleraxis as a prognostic marker of myocardial fibrosis in hypertrophic cardiomyopathy (SPARC) study
Antonia Zhu, Hilary Bews, David Cheung, et al.
Journal of Molecular and Cellular Cardiology
|
May 12, 2018
Regulation of cardiac fibroblast MMP2 gene expression by scleraxis
Raghu S Nagalingam, Hamza A Safi, Danah S Al-Hattab, et al.
Cells
|
May 14, 2022
Regulation of Cardiac Fibroblast GLS1 Expression by Scleraxis
Sikta Chattopadhyaya, Raghu S Nagalingam, D Allison Ledingham, et al.
Page
of 2